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responsibility of XAbstract Different fused-core stationary phase chemistries (C18, Amide, Phenyl-hexyl and
Peptide ES-C18) were used for the analysis of 21 structurally representative model peptides.
In addition, the effects of the mobile phase composition (ACN or MeOH as organic modiﬁer;
formic acid or acetic acid, as acidifying component) on the column selectivity, peak shape and
overall chromatographic performance were evaluated. The RP-amide column, combined with a
formic acid–acetonitrile based gradient system, performed as best. A peptide reversed-phase
retention model is proposed, consisting of 5 variables: log SumAA, log Sv, clog P, log nHDon and
log nHAcc. Quantitative structure-retention relationship (QSRR) models were constructed for
16 different chromatographic systems. The accuracy of this peptide retention model was
demonstrated by the comparison between predicted and experimentally obtained retention times,
explaining on average 86% of the variability. Moreover, using an external set of 5 validation
peptides, the predictive power of the model was also demonstrated. This peptide retention model
includes the novel in-silico calculated amino acid descriptor, AA, which was calculated from log P,
3D-MoRSE, RDF and WHIM descriptors.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.ersity. Production and hosting by E
.002
64 8100; fax: þ32 9 264 8193.
UGent.be (B. De Spiegeleer).
i’an Jiaotong University.1. Introduction
Peptides are of growing pharmaceutical interest because of
their biomedical activity attributed to their great diversity in
size, shape and chemical functionalities. They constitute an
emerging class of therapeutic agents, possessing greater efﬁ-
cacy and selectivity, as well as an inherent lower toxicity
proﬁle compared to the conventional small molecules [1].lsevier B.V. All rights reserved.
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liquid chromatography (RP-HPLC) has been most widely
employed [2–5]. In order to identify peptides in complex
mixtures, RP-HPLC is combined with mass spectrometry (LC-
MS), having an excellent sensitivity and selectivity [6,7].
Signiﬁcant progress in RP-HPLC was achieved with the
development of smaller, sub-2 mm particles enabling higher
resolutions and reduced analysis time [8]. Alternatively,
monolithic columns were constructed to speed up the separa-
tion and enhance the separating power [9,10]. Recently, fused-
core particles, comprising a 0.5 mm porous outer shell
(‘‘HALOs’’) fused to a 1.7 mm solid silica core (i.e. fused-
core, core-shell or core-enhanced technology) were developed
by Kirkland as an alternative to sub2 mm particles [11–13].
Different fused-core column chemistries are available: C18,
C8, RP-amide, Phenyl-hexyl, Hydrophilic Interaction Liquid
Chromatography (HILIC), and most recently Peptide ES-C18
and pentaﬂuorophenyl (PFP) phases (see Table 1).
Literature survey related to fused-core particle technology
demonstrated that most of the reports deal with the kinetic
performance evaluation of such columns using classic organic
model compounds [14–17]. Fused-core columns have been
characterized based on their Van Deemter curves, demonstrat-
ing high plate numbers, reduced mass transfers, and better
resolutions [14,18–20]. In order to demonstrate the superior
efﬁciency, performance and capacity of the fused-core sta-
tionary phases, those columns were compared to UPLC,
monolithic and conventional columns [21–25]. Because of
the high resolving power, 2D-HPLC has attracted more
attention and has been applied with the fused-core columns
in proteomic and metabolomic research [26–29]. Although the
separation of peptides using fused-core columns is scarce in
literature, these columns are found to be very promising to
reduce analysis time without reducing performance [1]. The
limited peptide research using the fused-core columns mostly
investigated the inﬂuence of temperature, gradient times and
ﬂow rate on the retention as well as selectivity and column
performance. Due to limited column chemistries currently
available for the fused-core stationary phases, lacking e.g. C4
or different polar embedded functionalities, most peptide
studies are usually carried out with the classic C18 bonded
chemistry. Some research groups compared the performance
of the C18 phases as manufactured by four different fused-
core suppliers (Advanced Materials Technology for HALOs
C18, Phenomenex for Kinetexs C18, Supelco for Ascentis
Expresss C18 and Agilent for Poroshells C18) [14,30–33].
Only three peptide studies applied the HALOs Peptide
ES-C18 fused-core stationary phase for a casein and a tryptic
digest, respectively [34–36], while the HALOs HILIC was
only once evaluated [37].
Up till now, no comparative study of the different chemistries
in fused-core columns for the analysis of peptides was performed.
Moreover, reversed-phase retention modeling using these col-
umns is also missing. In this work, different fused-core column
chemistries (HALOs C18, Peptide ES-C18, RP-amide and
Phenyl-hexyl) are compared and evaluated using a mixture of
synthetic peptides. In addition to the selectivity differences of the
stationary phases, the selectivity effects of the mobile phase
composition are studied as well [2,38–41]. Finally, reversed-phase
fused-core peptide retention models were constructed on the
different chromatographic systems, containing a novel in-silico
calculated amino acid descriptor.2. Materials and methods
2.1. Reagents
Ultra gradient grade acetonitrile was purchased from Romil
(Merelbeke, Belgium). Formic acid was obtained from Acros
Organics (Geel, Belgium). Water was puriﬁed in-house using
an Arium 611 puriﬁcation system (Sartorius, Go¨ttingen,
Germany), yielding Z18.2 MO cm quality water. Methanol
was supplied from Fisher Scientiﬁc (Leicestershire, UK) and
acetic acid from Merck (Darmstadt, Germany). All synthetic
peptides were synthesized by Peptide Protein Research (PPR,
Hampshire, UK) with a purity of at least 90%.2.2. Fused-core (HALOs) columns
Different column chemistries were selected, consisting of C18,
RP-amide, Phenyl-hexyl and Peptide ES-C18. Details about
the stationary phases, including the bonded phase, dimen-
sions, pore size, surface area and pH-range are given in
Table 1.
All HALOs columns have a particle size of 2.7 mm and
were supplied by Achrom (Machelen, Belgium).2.3. Peptide selection
In order to select a limited but representative experimental
peptide set, the chemical–structural diversity of 61 peptides
given in the Brainpepss database [42] was visualized using
principal component analysis (PCA) and hierarchical cluster
analysis (HCA). First, three-dimensional molecular structures
were calculated and optimized using Hyperchem 8.0 (Hyper-
cube Inc., Gainesville, FL, USA). Geometry optimization was
performed with the molecular mechanics force ﬁeld method
(MMþ) using the Polak-Ribiere conjugate gradient algorithm
with an RMS gradient of 0.1 kcal/(A˚.mol), corresponding to
0.4184 kJ/(A˚.mol), as stop criterion. The obtained structures
were then used to calculate more than 3000 molecular
descriptors (Dragon 5.5, Talete, Italy). After removal of
constant and correlated, i.e. Pearson correlation coefﬁcient
r40.95, descriptors, PCA and HCA was performed on the
normalized descriptors. In total, 21 peptides were selected
from the different peptide clusters, showing wide structural
variety. In addition, structurally related peptides belonging to
the same peptide cluster were selected as well for evaluation of
the chromatographic separation of structure analogs. More
detailed information regarding the 21 selected peptides, i.e.
molecular weight, log P and pI values, is given in Table 2.2.4. Peptide lyophilization
Prior to analysis, the peptide samples were dissolved in
acetonitrile/water 5/95 (v/v) containing 0.1% (w/v) formic
acid at a concentration of 1 mg/mL. 100 mL aliquots were
dispensed into low-volume polypropylene HPLC vials (Grace
Alltech, Deerﬁeld, US) and lyophilized with the in-house
developed program using a Christ gamma 1–16 LSC freeze
dryer (Qlab, Vilvoorde, Belgium) [43].
Table 1 Properties of the HALOs fused-core stationary phases.
Phase Bonded phase Pore
size
(A˚)
Surface
area
(m2/g)
Bonding
density
(mmol/m2)
Endcapped Base
deactivation
Dimensions
(l i.d.) (mm)
pH
range
C18
Octadecyldimethylsilane
90 150 3.5 Yes Yes 150 4.6 2–9
Peptide
ES-C18
Steric-protected C18,
octadecyldiisobutylsilane
160 80 2.0 No – 75 3.0 1–9
RP-amide
Alkyl amide
90 150 3.0 Yes Yes 150 4.6 2–9
Phenyl-hexyl
Phenyl-hexyl
90 150 3.4 Yes Yes 75 3.0 2–9
HILIC – 90 150 – – – 100 3.0 2–9
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The HPLC–PDA–MS apparatus consisted of a Waters Alliance
2695 separations module and a Waters 2996 photodiode array
detector with Empower 2 software for data acquisition (all
Waters, Milford, MA, USA). The MS apparatus, used for
identiﬁcation of the peptides, consisted of a Finnigan LCQ Classic
ion trap mass spectrometer in positive ion mode (all Thermo, San
Jose´, CA, USA) equipped with a Waters 2487 dual wavelength
absorbance UV detector (Waters, Milford, MA, USA) set at
215 nm and Xcalibur 2.0 software (Thermo, San Jose´, CA, USA)
for data acquisition. ESI was conducted using a needle voltage of
4.5 kV. Nitrogen was used as the sheath and auxiliary gas with the
heated capillary set at 250 1C. Positive mode mass spectra were
obtained in the range of m/z 100 to 2000.
The HALOs columns were thermostated in an oven set at
30 1C, whereas the autosampler temperature was set at 10 1C.
Four mobile phase compositions, traditionally employed in
peptide analysis, were used:(1) 0.1% w/v formic acid in water (A) and 0.1% w/v formic
acid in acetonitrile (B), referred to as FA.(2) 0.1% w/v formic acid in water (A) and 0.1% w/v formic
acid in methanol (B), abbreviated as FM.(3) 0.1% w/v acetic acid in water (A) and 0.1% w/v acetic
acid in acetonitrile (B), referred to as AA.(4) 0.1% w/v acetic acid in water (A) and 0.1% w/v acetic
acid in methanol (B), abbreviated as AM.The method consisted of a linear gradient from 90:10 v/v
A/B to 10:90 v/v A/B, followed by reconditioning with the
initial composition 90:10 v/v A/B for 10 min. The peptides
were injected as a mixture, each at a concentration of 25 mM,
dissolved in acetonitrile/water 5/95 (v/v) containing 0.1%
(w/v) formic acid. The injection volume was ﬁxed to 5 mL.
Seen the different column dimensions, the gradient time and
ﬂow rate were adjusted taking into account the column
volume according to the following formula:
tG;2 ¼ tG;1 
V0;2
V0;1
 F1
F2
where tG,2 and tG,1 are the gradient times of HPLC column 2
and 1, respectively, F is the ﬂow rate and V0 is the dead
volume. The ﬂow rate was set to 0.5 mL/min (except for
mobile phase system FA, a ﬂow rate of 1 mL/min was used)
with a gradient time of 25 min on the C18 and RP-amide
column, while for the other two phases, Phenyl-hexyl and
Table 2 Overview of selected peptides (21 model-building
and 5 validation peptides).
Peptide MW (g/mol) log P pI
Adrenomedullin 5730.46 38.53 10.39
Amylin 3921.43 26.06 10.81
cHP 234.26 1.26 8.81
CRH 4758.50 20.78 5.59
CTOP 1062.27 1.40 9.41
Dermorphin 802.88 1.24 9.16
Des-octanoyl ghrelin 3188.65 21.81 10.67
DPDPE 645.79 0.87 5.70
Endomorphin-1 610.71 1.76 8.61
GALP rat 6502.44 31.07 10.17
Kyotorphin 337.38 0.07 8.74
LHRH 1183.29 4.14 8.08
Mouse Obestatin 2516.85 12.96 9.81
MCH 2386.84 5.52 8.85
Met5-Enkephalin 573.66 0.69 5.82
Orexin A 3561.14 17.35 9.71
RC-160 1131.38 1.50 9.73
SB-Aba 580.68 0.05 10.28
UCN-I 4708.04 19.32 5.70
VDE243 671.75 0.62 5.87
VIP 3326.83 16.19 9.71
Endomorphin-2 571.68 1.99 8.61
Neuropeptide Y 4254.70 17.73 8.05
Phe13Tyr19-MCH 2434.88 4.71 8.85
TAPP 545.64 2.62 8.61
Urocortin II 4153.94 14.84 10.57
M. D’Hondt et al.96Peptide ES-C18, the ﬂow rate was 0.4 mL/min (except for
mobile phase system FA, a ﬂow rate of 0.6 mL/min was used)
with a gradient time of 10 min. A number of single and
multiple chromatographic responses were calculated using the
aforementioned 16 different chromatographic systems, includ-
ing asymmetry factor (As), full width half maximum
(FWHM), gradient plate number (Ng) and chromatographic
response factor (CRF) [44].
2.6. In-silico amino acid descriptor
Structural descriptors (911) belonging to different classes (i.e.
constitutional, topological, topological charge, geometrical,
RDF, 3D-MoRSE, Weighed Holistic Invariant Molecular
(WHIM), GETAWAY, charge descriptors and molecular prop-
erties) were calculated using the optimized three-dimensional
structures of the 20 naturally occurring amino acids. After
elimination of the constant descriptors, a stepwise multiple
linear regression (MLR), as implemented in SPSS 20.0 (P-to-
enter r0.05 and P-to-remove Z0.10), was used to model the
experimentally obtained retention times of the 20 natural amino
acids on a XTerra MS C18 column [45] in function of their
calculated structural descriptors.
2.7. Peptide retention model
In order to predict the gradient retention time of peptides on the
different fused-core columns, quantitative structure-retention
relationships (QSRR) were established for the 16 experimental
chromatographic conditions. The peptide retention time ismodeled as a function of a limited set of molecular descriptors
by means of MLR. Generally, current peptides RP-HPLC
QSRR models have the following equation form [46–51]:
RT ¼ b0 þ b1logSumAA þ b2logVDWvol þ b3clogP
where RT is the peptides gradient RP-HPLC retention time,
b0b3 are regression coefﬁcients estimated by MLR, log SumAA
is the logarithm of the sum of the experimentally obtained
gradient retention times of the amino acids composing the
individual peptide, log VDWvol is the logarithm of the peptide’s
van der Waals volume and clog P is the logarithm of its
theoretically calculated n-octanol–water partition coefﬁcient
according to the Ghose–Pritchett–Crippen algorithm.
In our proposed peptide reversed-phase fused-core retention
model, similar molecular descriptors were used. log SumAA,
however applying the new in-silico calculated descriptor described
above replacing the experimentally determined amino acid reten-
tion times, log Sv (i.e. van der Waals volume calculated with
Dragon software) and clog P. In addition to these three descrip-
tors, the number of donor and acceptor atoms for H-bonding
(nHDon and nHAcc, respectively) were added as proposed in
RP-HPLC by Du et al. [52]. The descriptor log SumAA is thus no
longer experimentally determined, but is calculated in terms of
theoretical descriptors, so that the peptide retention can be
predicted entirely in-silico, without the need of experiments with
each of the amino acids constituting the peptide.
Finally, the predictive power of the newly proposed peptide
retention model was demonstrated by calculating the retention
times of ﬁve validation peptide (Table 2), belonging to the
same structural space of the 21 model-building peptides, and
comparing these predicted retention times to the experimen-
tally obtained retention times using the 16 different chromato-
graphic systems.3. Results
3.1. Chromatographic properties of peptides on fused-core
stationary phases
A typical chromatogram of UCN-1, MCH and dermorphin on
the RP-amide column using FA is shown in Fig. 1. The
inﬂuence of the mobile phase composition on the column
performance was demonstrated by the calculation of the
gradient plate number (Ng). The highest plate number was
observed for FA on all four columns, with the RP-amide
column exceeding the others. The performance of the columns
was lowered signiﬁcantly when using MeOH as organic
modiﬁer compared to ACN. Also when looking at FWHM
and As, the FA mobile phase composition was generally found
to be the best performing mobile phase throughout all
columns. When using this mobile phase, i.e. FA, the
RP-amide column displayed the best As and second best
FWHM, and was thus considered to overall deliver the best
peak shapes. When calculating the other chromatographic
performance response functions, i.e. resolution product cor-
rected for the retention time of the last eluting peak, separa-
tion factor, CRF and peak capacity, the highest values (i.e.
better separation of compounds) were again obtained using
FA. Also for these chromatographic response factors, the RP-
amide column performed the best, followed by C18, Peptide
ES-C18 and Phenyl-hexyl.
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Stepwise MLR, whereby 742 non-constant structural descrip-
tors, derived from the three dimensional amino acid struc-
tures, were modeled into a global in-silico amino acid
descriptor, describing the reversed-phase retention behavior
as given in the literature [45], resulted in following model:
AAdescriptor ¼ 4:131 Alog Pþ 1:330 Alog P217:517 Mor10v
þ6:613 Mor10eþ 9:302E1u
þ0:240RDF035e20:692
This new in-silico calculated AA descriptor was introduced
into the existing peptide retention models, thus replacing the
experimentally determined individual amino acids retention
times. Linear least squares correlation analysis indicated that
this AA model explained 99.4% of the observed amino acid
retention variability (R2¼0.994).
3.3. Peptide retention model
Sixteen separate QSRR models were developed for each of the
sixteen chromatographic conditions, using following general
equation:
RT ¼ b0 þ b1log
X
AAdescriptor þ b2clog Pþ b3log Sv
þb4log nHDonþ b5log nHAcc
The QSRR results are summarized in Table 3. Obtained R2
and F values for the prediction models as well as the calculated
regression coefﬁcients are tabulated. On average, 85.7% of the
peptide retention time variability is explained by our proposed
model. Scatter plots of the sixteen chromatographic condi-
tions, displaying the 21 calculated peptide retention times in
function of the experimentally obtained retention times are
given in Fig. 2.
The predictive power of the peptide retention model is
shown in Fig. 3, whereby the calculated peptide retention timeA
U
-0.10
-0.08
-0.06
-0.04
-0.02
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
0.26
0.28
0.30
Time (min)
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00
Fig. 1 Typical chromatograms: MCH, UCN-1 and dermorphin
(from top to bottom) on HALOs RP-amide column, using formic
acid–acetonitrile based chromatography.of 5 validation peptides is depicted versus their experimentally
obtained retention times, characterized by an average R2 value
of 0.80.4. Discussion
Application of small, sub2 mm, fully porous particles results in a
higher efﬁciency, linear velocity and reduced mass transfer, but also
requires special instrumentation (Ultra-Performance Liquid Chro-
matography, UPLC) to cope with the resulting pressure increase
[53]. The use of monolithic columns allows to speed up the
separation and enhance the separating power [9,10]. The main
drawback of these monolithic columns is the relatively high ﬂow
rate required to fully exploit their potential. Alternatively, fused-
core particles achieve high separation efﬁciencies with relative low
backpressure, permitting the use of conventional HPLC equipment
[1,11,54]. Due to their small particle size and limited diffusion path,
plate numbers equivalent to UPLC are achieved, minimizing peak
broadening, while overall shortening the analysis time [10,55,56].
Compared to conventional HPLC columns of the same dimen-
sions, usually packed with 3–5 mm particles, the fused-core columns
show a signiﬁcant gain in performance, expressed as plate number
or peak capacity [1].
Multiple fused-core particle chemistries are available (see
Table 1). C18 and C8 are used for the separation of hydro-
phobic compounds whereas the fused-core RP-amide column
is a polar-embedded phase, providing enhanced selectivity for
samples containing highly water-soluble acidic and basic
compounds. Separation on the RP-amide column is affected
by hydrophobic interaction with the alkyl chain and hydrogen
bonding with the embedded amide group. For the phenyl-
hexyl fused-core column, an additional p–p mechanism is
described for the separation of aromatic groups. The PFP
phase is recommended for the separation of polar bases and
halogenated compounds. The primary HILIC retention
mechanism is based on hydrophilic partition between the
water-rich layer at the surface of the stationary phase and
the bulk organic-rich mobile phase [37,44,57]. As an extension
of the C18 phase, the Peptide ES-C18 phase was speciﬁcally
designed for the enhanced separation of peptides due to the
carefully selected pore size and the use of extra stable (ES)
bonding chemistry. Therefore, 100, 120 or 160 A˚ was selected
as the ideal pore size for optimal separation of peptides with a
molecular weight of up to 15,000 Da, contrasting a pore size
of 90 A˚ for small molecules. Extra stable bonding was
achieved through the use of bulky side chains on the
alkylsilanes, providing steric protections of the more labile
siloxane bond [34].
Peptide clustering, based on their theoretical descriptors,
revealed consistent grouping between HCA and PCA and was
used to select a representative peptide set, consisting of 21
peptides from different clusters, for further chromatographic
analysis.
These wide structure differences were conﬁrmed by the
diverse chromatographic behavior of the 21 selected peptides
using the different chromatographic systems. In general it was
seen that peptide separation on the RP-amide fused-core
column, using the formic acid–acetonitrile based mobile phase,
resulted in the best chromatographic responses, thus out-
performing the Peptide column. A possible explanation is the
additional hydrogen bond interactions between the amide
Table 3 Retention models obtained on the four fused-core columns using multiple linear regression.
Column MPa Retention models RT¼b0þb1 log
P
AA descriptorþb2 clog
Pþb3 log Svþb4 log nHDonþb5 log nHAcc
Experimental vs. predicted model
ﬁt predicted RT¼aExperimental RTþb
R2 F b0 b1 b2 b3 b4 b5 a b
Peptide ES-C18 FA 0.818 13.448 3.698 8.352 0.075 3.030 9.095 8.096 0.818 0.694
FM 0.913 31.317 5.389 13.011 0.101 3.695 10.925 9.082 0.912 0.670
AA 0.826 14.210 3.582 9.932 0.089 3.694 9.935 8.631 0.825 0.842
AM 0.916 32.603 7.162 12.847 0.128 2.830 12.110 10.410 0.916 0.632
RP-amide FA 0.817 13.385 7.445 14.750 0.140 5.845 17.287 16.202 0.817 1.086
FM 0.845 16.401 10.615 30.793 0.217 13.321 29.263 26.367 0.845 2.119
AA 0.857 17.956 5.582 18.575 0.145 9.002 20.325 18.815 0.857 1.104
AM 0.857 18.003 15.790 32.709 0.271 13.783 39.538 36.968 0.857 1.787
Phenyl-hexyl FA 0.796 11.736 1.215 7.356 0.044 3.315 5.332 4.209 0.797 0.707
FM 0.901 27.412 3.360 14.479 0.083 5.777 10.382 8.278 0.901 0.750
AA 0.800 11.967 2.466 9.910 0.081 4.195 9.285 7.835 0.800 0.926
AM 0.890 24.202 6.223 14.274 0.115 4.057 13.080 10.724 0.890 0.848
C18 FA 0.834 15.023 7.006 14.159 0.113 5.683 16.758 15.644 0.833 0.970
FM 0.892 24.810 10.790 29.263 0.181 11.703 29.591 26.210 0.892 1.498
AA 0.851 17.175 6.211 18.308 0.124 8.671 21.040 19.491 0.851 1.125
AM 0.903 27.875 14.259 30.967 0.220 12.470 35.679 32.723 0.903 1.266
aMP¼mobile phase, FA¼formic acid–acetonitrile, FM¼formic acid–methanol, AA¼acetic acid–acetonitrile, AM¼acetic acid–
methanol.
Fig. 2 Peptide retention model.
M. D’Hondt et al.98groups of the column and the peptides, which are absent in the
Peptide column, resulting in a higher selectivity of the RP-
amide column. The acid in the mobile phase serves not only apH control function, but also an ion-pairing complexation
activity with the charged peptide ionic groups and the
stationary phase, and will additionally suppress adverse ionic
Fig. 3 Predictive power of the peptide retention model.
Reversed-phase fused-core HPLC modeling of peptides 99interactions between the peptides and the residual silanol
groups on the stationary phase. The use of acetic acid, being
more hydrophobic than formic acid, leads to increased peptide
retention on the column, which in turn leads to increased
resolution [58]. Therefore, hydrophobic ion-pairing agents,
e.g. acetic acid, should be used for separation of complex and/
or structurally related peptides, whereas more hydrophilic
agents, e.g. formic acid, can be used for fast separation of
simple peptide mixtures. As such, the acidic mobile phase
additives will also inﬂuence the selectivity, its extent depending
on the stationary phase.
The classic, experimentally obtained individual amino acid
retention times descriptor was replaced by an in-silico calculated
AA descriptor using a stepwise MLR. This new descriptor is
calculated using six structural descriptors. The ﬁrst two descrip-
tors, i.e. Alog P and Alog P2, give information about the
lipophilicity of amino acids whereby Alog P2 is the square of
the Alog P value. This Alog P value is calculated using the
Ghose-Crippen-algorithm. Mor10v and Mor10e are part of the
3D-Molecule Representation of Structures based on Electron
diffraction (3D-MoRSE) descriptors, which provide information
derived from the three dimensional coordinates by using the
same transformation used in electron diffraction to prepare
theoretical scattering curves. These different signals, i.e. indi-
cated by the numeric code, were then weighed by van der Waalsvolume (v) or by Sanderson electronegativity (e). E1u stands for
the unweighed 1st component accessibility directional WHIM
index. This is a geometrical descriptor based on statistical
indices, calculated from the projections of the atoms along
principal axes. The Radial Distribution Function (RDF)
descriptors are based on the distance distribution in the
geometrical representation of a molecule, and show certain
characteristics in common with the 3D-MoRSE descriptors.
The RDF descriptors provide information about interatomic
distances in which the numeric code indicates an interatomic
distance, e.g. 035 corresponding to 3.5 A˚, which is the prob-
ability of ﬁnding an interatomic distance of 3.5 A˚. Similar
weighing factors as for the 3D-MoRSE descriptors are used [59].
This new in-silico AA descriptor was then introduced into
the peptide retention model, of which 16 different QSRR were
constructed, modeling the peptide retention times on the 16
different chromatographic conditions used. The proposed
model factors differ signiﬁcantly from the existing reversed-
phase peptide retention model factors: our model not only
includes the new in-silico amino acid descriptor, but also
includes number of hydrogen donors (nHDon) and hydrogen
acceptors (nHAcc). The existing models all use the experi-
mentally determined retention time or factor of the individual
amino acids as amino acid descriptor and available amino acid
descriptors did not include new and/or unnatural amino acids
M. D’Hondt et al.100[60]. Our new amino acid descriptor allows the modeling of
peptides containing unnatural amino acids including optical
isomers (L versus D) as well. The predictive power of our peptide
retention models demonstrated the correlation of the predicted
retention times versus experimentally obtained for 5 peptides not
included in our model building set (mean R2¼0.800) (Fig. 3).5. Conclusion
Fused-core columns are of great interest because of their high
performance in combination with a relatively low backpres-
sure allowing the application of these columns on conven-
tional HPLC equipment. Four different column chemistries
(Peptide, RP-amide, Phenyl-hexyl and C18) were compared
for the separation of 21 selected, structurally diverse, peptides.
Highest chromatographic responses were obtained using the RP-
amide column and formic acid-acetonitrile based gradient system.
A reversed-phase QSRR retention model was constructed
for peptide analysis on the fused-core stationary phases under
the sixteen given chromatographic conditions. This model
incorporates a novel, in-silico calculated amino acid descrip-
tor, thus rendering the determination of individual amino acid
retention times superﬂuous and allowing the inclusion of new
unnatural amino acids in the construction of the QSRR
model. The model explained 86% of the observed peptide
retention time variability and had a predictive power of 80%.
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